Sign up to save your podcasts
Or
Share Ep. 122: Tesla accounting, Adaptive Biotech’s cancer blood test, IBM and AutoNation
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Ep. 122: Tesla accounting, Adaptive Biotech’s cancer blood test, IBM and AutoNation
A blood test for cancer? Adaptive Biotech founders Chad and Harlan Robins explain. (Yes, they’re brothers!) (ADPT) Tesla’s novel accounting treatment for non-existent Full Self Driving Cars (TSLA). AutoNation says car shortages will persist through 2023 (AN). The Incredible Shrinking IBM. The Drill Down with Cory Johnson offers a daily look at the business stories behind stocks on the move.
Learn more about your ad choices. Visit megaphone.fm/adchoices
View all episodes
By Cory Johnson
5
3232 ratings
A blood test for cancer? Adaptive Biotech founders Chad and Harlan Robins explain. (Yes, they’re brothers!) (ADPT) Tesla’s novel accounting treatment for non-existent Full Self Driving Cars (TSLA). AutoNation says car shortages will persist through 2023 (AN). The Incredible Shrinking IBM. The Drill Down with Cory Johnson offers a daily look at the business stories behind stocks on the move.
Learn more about your ad choices. Visit megaphone.fm/adchoices
More shows like The Drill Down
View all
Motley Fool Money
3,177 Listeners
This Week in Startups
1,282 Listeners
a16z Podcast
1,040 Listeners
Top Traders Unplugged
580 Listeners
Acquired
4,200 Listeners
Zacks Market Edge
295 Listeners
Odd Lots
1,795 Listeners
Macro Voices
3,064 Listeners
Invest Like the Best with Patrick O'Shaughnessy
2,287 Listeners
Grant’s Current Yield Podcast
664 Listeners
Superinvestors and the Art of Worldly Wisdom
416 Listeners
FYI - For Your Innovation
386 Listeners
RenMac
74 Listeners
All-In with Chamath, Jason, Sacks & Friedberg
9,216 Listeners
BG2Pod with Brad Gerstner and Bill Gurley
464 Listeners